The Atrial Fibrillation Registry (The FLOW‐AF Registry): Insights From the United Arab Emirates—Patient Characteristics, Treatment, and One‐Year Outcomes
Journal of Cardiovascular Electrophysiology · 2025-04 · 36 (4) · 813-823
DOI: 10.1111/jce.16598 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 10.02.2025. Verfasst von Moutaz El Kadri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The study was sponsored by Pfizer..
Abstract (Originalsprache)
Background
The epidemiological landscape and treatment efficacy of atrial fibrillation (AF) in the Middle East, notably in the United Arab Emirates (UAE), remain under‐explored, presenting a distinct demographic and clinical pattern compared to Western populations. The FLOW‐AF Registry aimed to bridge this knowledge gap by examining the characteristics, treatment patterns, clinical outcomes, and healthcare resource utilization (HCRU) of newly diagnosed non‐valvular atrial fibrillation (NVAF) patients in the UAE, contributing to the scant literature on NVAF management in the region.
Methods
This multicenter, prospective observational study enrolled patients diagnosed with NVAF across six sites in the UAE. Data were collected on demographics, medical history, treatment decisions, clinical outcomes, and HCRU over a 12‐month observation period.
Results
A total of 198 patients were enrolled, with a mean age of 63.44 years. Mean CHA₂DS₂‐VASc and HAS‐BLED scores at baseline were 2.95 and 1.76, respectively. Most patients (55.77%) were prescribed non‐vitamin K antagonist oral anticoagulants (NOACs). One‐year incidence rates for major clinical events were 6.7% for all‐cause mortality, 2.8% for bleeding complications, and 0.6% for myocardial infarction. No strokes were reported during the study period.
Conclusion
The FLOW‐AF Registry provides valuable insights into NVAF management in the UAE, demonstrating a distinct patient profile and a preference for NOACs. The NVAF cohort in the UAE was characterized by a younger demographic with lower risk scores and lower rate of clinical events relative to global counterparts. The findings underscore the evolving approach to AF management in the UAE, suggestive of a shift towards NOAC use but also highlights the need for ongoing research to fully understand long‐term outcomes and validate current treatment paradigms in the UAE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
- Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
- Fujairah Hospital, EHS, Fujairah, United Arab Emirates.
- Dubai Hospital, Dubai, United Arab Emirates.
- Pfizer Gulf, Dubai, United Arab Emirates.
- IQVIA, Real-World Evidence, Dubai, United Arab Emirates.
ORCID-Profile: Haytham Mohamed Ahmed, Wael A Almahmeed
Förderung
- The study was sponsored by Pfizer.
Zitieren
APA
El Kadri, M., AlMuti, K., Agrawal, A., Bazargani, N., Gamaleldin, M. F. S., Ahmed, H. M., Hassanain, O., Khalife, N., Radaideh, G., Magdy, M., & Almahmeed, W. A. (2025). The Atrial Fibrillation Registry (The FLOW‐AF Registry): Insights From the United Arab Emirates—Patient Characteristics, Treatment, and One‐Year Outcomes. Journal of Cardiovascular Electrophysiology, 36(4), 813-823. https://doi.org/10.1111/jce.16598
Vancouver
El Kadri M, AlMuti K, Agrawal A, Bazargani N, Gamaleldin MFS, Ahmed HM, et al. The Atrial Fibrillation Registry (The FLOW‐AF Registry): Insights From the United Arab Emirates—Patient Characteristics, Treatment, and One‐Year Outcomes. Journal of Cardiovascular Electrophysiology. 2025;36(4):813-823. doi:10.1111/jce.16598
BibTeX
@article{ElKadri2025,
author = {El Kadri, Moutaz and AlMuti, Khalid and Agrawal, Amrish and Bazargani, Nooshin and Gamaleldin, Mohamed Fathy Soliman and Ahmed, Haytham Mohamed and Hassanain, Omneya and Khalife, Natasha and Radaideh, Ghazi and Magdy, Mohamed and Almahmeed, Wael A},
title = {The Atrial Fibrillation Registry (The FLOW‐AF Registry): Insights From the United Arab Emirates—Patient Characteristics, Treatment, and One‐Year Outcomes},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
volume = {36},
number = {4},
pages = {813--823},
doi = {10.1111/jce.16598}
}
EUVIMED